Previous studies showed that DUSP9 was directly involved in the development of multiple tumors, including hepatocellular carcinoma, breast cancer, renal carcinoma, gastric carcinoma and colorectal carcinoma 29. This evidence concerns the gene DUSP9 and renal carcinoma.